Adaptogens for Dogs: The Strict-Definition Guide to Adaptogenic Herbs for Stress, Resilience, and Healthy Ageing

Summary

Adaptogenic herbs for dogs are botanicals that meet a strict pharmacological definition: they raise non-specific resistance to stress, exert a normalising effect on physiology regardless of the direction of disturbance, and remain safe at therapeutic doses. Many herbs marketed as adaptogens, including turmeric, ginger, and echinacea, do not meet these criteria. Six botanicals carry the strongest evidence as Core adaptogens (Ashwagandha, Rhodiola, Panax Ginseng, Eleuthero, Schisandra, Holy Basil), and a further six (Astragalus, Cordyceps, Reishi, Maca, Liquorice, Shatavari) qualify as Secondary adaptogens. In dogs, peer-reviewed randomised controlled trials now document measurable cortisol reduction, anti-inflammatory action, and microbiome modulation from Ashwagandha, with translational evidence supporting the wider category. This guide separates the genuine from the merely marketed and explains how strict-definition adaptogens fit canine stress, resilience, and healthy-ageing strategies.

---

The word adaptogen has travelled a long way from its scientific origin. Coined in Soviet pharmacology in the late 1940s and formalised by Brekhman and Dardymov in 1969, it once described a narrow, defensible category of botanicals with a specific pharmacological profile.¹,² Today it sits on packaging for everything from turmeric capsules to bedtime teas. For dog owners, this matters. The word has become almost meaningless on a label, and that loss of meaning has practical consequences when you are choosing supplements or food for a stressed, ageing, or chronically reactive dog.

This guide reinstates the strict definition. It explains what an adaptogen actually is, names the twelve botanicals that meet the criteria, identifies the herbs commonly mislabelled as adaptogens, distinguishes adaptogens from calming nervines, and walks through how this category of compound supports canine physiology through the hypothalamic-pituitary-adrenal (HPA) axis and the gut-organ axes. It draws on the strongest available evidence base, including three peer-reviewed canine randomised controlled trials of Ashwagandha published since 2022.³,⁴,⁵

The framework matters more than any single ingredient. A dog dealing with chronic environmental stress, a dog entering its senior years, a dog recovering from illness, and a dog living in a multi-pet household with unresolved tension will all benefit from the same physiological principle: a botanical category that helps the body return to equilibrium rather than amplifying any one direction of response.

Key Takeaways

• Adaptogens are defined by three strict pharmacological criteria, not by traditional or marketing use.
• Only twelve botanicals carry credible adaptogen taxonomy: six Core, six Secondary.
• Turmeric, ginger, echinacea, ginkgo, and milk thistle are not adaptogens despite frequent labelling as such.
• Chamomile, lavender, passionflower, and lemon balm are calming nervines, a separate functional category.
• The mechanism shared by true adaptogens is bidirectional modulation of the HPA axis and the cellular stress-response system.
• Canine RCTs now provide direct evidence for Ashwagandha; translational evidence supports the wider category.
• The Bonza range is architected around strict-definition adaptogens: four (Ashwagandha, Panax Ginseng, Eleuthero, Reishi) in the PhytoPlus® blend in Superfoods & Ancient Grains, with Ashwagandha and Eleuthero also applied to specific Bioactive Bites where their pharmacology aligns with the functional class.
• Adaptogens act systemically on stress physiology, which means the gut-brain, gut-immune, and gut-longevity axes are all relevant routes of effect.
• Safety at therapeutic dose is part of the definition, but contraindications exist and species-appropriate dosing is essential.

In This Guide

• What Adaptogens Are: The Strict Definition That Separates Real From Marketed
• The Three Criteria Every True Adaptogen Must Meet
• Core Adaptogens: The Six With the Strongest Evidence Base
• Secondary Adaptogens: Six More With Documented Adaptogenic Action
• Commonly Mislabelled: Why Turmeric, Ginger, and Echinacea Are Not Adaptogens
• Adaptogens Are Not Calming Herbs: A Critical Distinction
• How Adaptogens Work in Dogs: HPA Axis, Cortisol Modulation, and Allostatic Load
• Adaptogens and the Gut-Organ Axes
• Safety, Dosage, and When Adaptogens Should Not Be Used in Dogs
• Why the Bonza Range Is Built Around Strict-Definition Adaptogens
• How to Choose Adaptogenic Support for Your Dog: A Practical Framework
• Frequently Asked Questions
• Conclusion
• Related Articles
• References
• Editorial Information

What Adaptogens Are: The Strict Definition That Separates Real From Marketed

An adaptogen is a substance that increases an organism’s non-specific resistance to stress, normalises physiology regardless of the direction of disturbance, and does so without harm at therapeutic dose. That definition was formalised by Brekhman and Dardymov in 1969 and has been reinforced by every major pharmacological review since.¹,² It is not a marketing term. It is a pharmacological category, comparable in specificity to terms like beta-blocker or selective serotonin reuptake inhibitor.

The word’s drift in popular usage matters because it changes what dog owners think they are buying. A bottle labelled “adaptogen blend” might contain a strict-definition adaptogen, a functional herb with a different mechanism, a calming nervine, or a mixture of all three. The pharmacology of those categories is genuinely different, and so are the outcomes you should expect.

The strict definition originated in Soviet research into substances that could improve resilience and performance under extreme physical stress, including military and athletic contexts. Brekhman, Lazarev, and colleagues observed that certain plants, beginning with Schisandra chinensis and later Eleutherococcus senticosus (Siberian Ginseng), produced a measurable shift in how organisms responded to a wide range of stressors rather than addressing any single symptom or system.¹ The concept was later mapped onto modern stress physiology, particularly the hypothalamic-pituitary-adrenal (HPA) axis and the cellular heat-shock response, by Panossian and others.¹,²

What this means in practical terms: a true adaptogen does not simply “calm” a dog or “energise” a dog. It changes how the dog’s stress-response machinery handles whatever it is asked to handle. The same herb that helps a high-anxiety dog quieten can also help a flat, depressed, lethargic dog regain drive, because the action is normalising rather than directional. That bidirectional quality is the single most distinctive feature of the category.

The Three Criteria Every True Adaptogen Must Meet

Three criteria define a strict-taxonomy adaptogen, and every botanical in the recognised category meets all three. The criteria are non-specific stress resistance, a normalising action, and innocuous behaviour at therapeutic dose.¹,²

The three criteria operate as a tight pharmacological filter:

• Non-specific resistance. The substance must increase resistance to a wide range of stressors, including physical (cold, exertion, sleep restriction), chemical (toxins, drugs), and biological (infection, immune challenge). A herb that only reduces inflammation, or only sedates, or only stimulates immunity, fails this test.
• Normalising action. The substance must move physiology toward equilibrium regardless of the direction of disturbance. If cortisol is too high, it tends downward. If cortisol is suppressed, it tends upward. The same applies across blood pressure, immune activation, and other regulated systems. This bidirectional behaviour is the most pharmacologically distinctive feature.
• Innocuous at therapeutic dose. The substance must not significantly disturb normal physiological function in healthy individuals at the doses required for effect. This is not the same as “no contraindications”. It means that the safety profile at active doses is favourable enough to use as a long-term modulator rather than a short-term agent.

Each of these criteria has been tested for the recognised adaptogens in animal models, isolated cell systems, and human clinical trials. The category emerged because a handful of plants kept passing all three filters across decades of independent investigation.¹,²

Core Adaptogens: The Six With the Strongest Evidence Base

The Core adaptogens are six botanicals with the most extensive pharmacological and clinical evidence base across the three defining criteria. They are Ashwagandha, Rhodiola, Panax Ginseng, Eleuthero, Schisandra, and Holy Basil. Each carries decades of human and animal research, identifiable bioactive constituents, and documented effects on the HPA axis and the cellular stress response.¹,²

Ashwagandha (Withania somnifera)

Ashwagandha is the most thoroughly studied adaptogen in canine medicine, with three peer-reviewed randomised controlled trials in dogs published since 2022.³,⁴,⁵ The bioactive profile is dominated by withanolides, with withaferin A as the most pharmacologically characterised compound. The mechanism includes HPA-axis modulation, anti-inflammatory action via NF-κB inhibition, and antioxidant support through superoxide dismutase, catalase, and glutathione modulation.⁴

In a 2022 randomised, double-blind, placebo-controlled trial, Kaur and colleagues administered standardised Ashwagandha root extract at 15 mg/kg body weight to 24 dogs experiencing stress and anxiety, and found a statistically significant reduction in urinary cortisol-to-creatinine ratio after four weeks compared with placebo.³ A 2024 Vet Med Sci trial in geriatric dogs (Bharani and colleagues) at the same dose for 60 days showed reductions in serum cortisol, key inflammatory cytokines (interferon-γ, tumour necrosis factor-α, NF-κB), and improvements in haematological and antioxidant parameters.⁴ A 2025 trial in geriatric Beagles documented gut-specific benefits including improved faecal score, increased L-citrulline (a marker of intestinal integrity), and elevated propionic acid and total short-chain fatty acid levels.⁵

For Bonza dogs, Ashwagandha is incorporated across the range. It appears in the PhytoPlus® botanical blend in Superfoods & Ancient Grains and in three Bioactive Bites supplements where its pharmacology aligns with the functional class: Bliss for HPA-axis and cortisol modulation in calming and anxiety contexts, Bounce for anti-inflammatory and antioxidant support in joint and mobility contexts, and Boost for stress-resilience and antioxidant support in whole-body wellness contexts.

Rhodiola (Rhodiola rosea)

Rhodiola is one of the most clinically studied adaptogens for fatigue, stress-induced cognitive decline, and physical endurance in human research, with translational evidence supporting effects in animal models.⁶ The bioactive profile is dominated by salidroside (rhodioloside) and the rosavins (rosavin, rosin, rosarin), with the rosavins serving as a genus-specific marker that distinguishes R. rosea from other Rhodiola species.⁶ Standardised extracts are typically calibrated to a 3:1 ratio of rosavins to salidroside.

Mechanism includes modulation of monoamine neurotransmitters (serotonin, dopamine, norepinephrine), induction of stress-response heat-shock proteins (Hsp70), and bidirectional cortisol modulation.¹,²,⁶ Canine-specific clinical trials of Rhodiola remain limited, so its place in dog supplements should currently rest on the strength of translational evidence rather than direct intervention data, with veterinary supervision recommended for dogs on cardiovascular or psychotropic medication.

Panax Ginseng (Panax ginseng)

Panax ginseng is the original adaptogen reference plant of East Asian herbal medicine and has been included in major pharmacopoeias as an adaptogenic herb.⁷ The bioactive profile is built around ginsenosides, a class of triterpene saponins with structural similarity to steroid hormones, which underpins their interaction with the HPA axis.

Pharmacologically, ginseng’s adaptogenic effect is best characterised as bidirectional modulation across cardiovascular, neuroendocrine, and immune systems: in states of hypercortisolism, ginsenosides downregulate cortisol output, and in states of suboptimal adrenal function they support steroidogenesis.⁷ This bidirectional behaviour is the canonical example of normalising action. Direct canine intervention trials remain limited, but the species has been used historically in canine herbal practice and has a documented safety profile in companion animal contexts at appropriate doses. As with Rhodiola, veterinary input is sensible for dogs on concurrent medication.

Panax Ginseng is included in the PhytoPlus® botanical blend in Superfoods & Ancient Grains, alongside Ashwagandha and Eleuthero, making it the third Core adaptogen in the food’s botanical blend.

Eleuthero / Siberian Ginseng (Eleutherococcus senticosus)

Eleuthero is the adaptogen on which the modern category was effectively built, having been the principal subject of Brekhman and Dardymov’s foundational pharmacological work.¹,⁸ The European Medicines Agency has approved E. senticosus root for the treatment of symptoms of asthenia, including fatigue and weakness, in human medicine.⁸

The bioactive profile is dominated by eleutherosides, particularly syringin (eleutheroside B) and the syringaresinol diglucoside eleutheroside E, alongside caffeoylquinic acids and immunomodulatory polysaccharides. Pharmacological action includes inhibition of MAPK and NF-κB signalling, neuroprotective effects via brain-derived neurotrophic factor, and immunomodulatory activity.⁸ A characteristic feature is a biphasic dose-response curve in which low and intermediate doses produce adaptogenic activity while high doses do not, consistent with the broader adaptogen pattern.⁸

For Bonza dogs, Eleuthero appears in the PhytoPlus® botanical blend in Superfoods & Ancient Grains and in Boost Bioactive Bites, where its anti-fatigue, neuroprotective, and physical-performance pharmacology supports the supplement’s whole-body wellness positioning.

Schisandra (Schisandra chinensis)

Schisandra was, alongside Eleuthero, one of the original adaptogens to enter Soviet pharmacopoeias and remains among the best-characterised adaptogens for hepatic support, oxidative stress, and cognitive performance.⁹ The bioactive profile centres on dibenzocyclooctadiene lignans, a genus-specific class with schisandrin (schisandrol A), schisandrin B (gomisin N), and gomisin A as the principal compounds.

Pharmacologically, S. chinensis has been documented to exhibit adaptogenic, hepatoprotective, immunostimulant, antioxidant, and anti-stress activities.⁹ The lignans support phase I and phase II hepatic enzyme systems, which is mechanistically relevant to the gut-liver axis in dogs. Direct canine clinical evidence is limited, and Schisandra is not currently a Bonza ingredient. It remains a meaningful future spoke for dogs requiring a hepatic-leaning adaptogen.

Holy Basil / Tulsi (Ocimum sanctum)

Holy Basil, also known as Tulsi, is one of the most thoroughly researched adaptogens for HPA-axis activity in modern human clinical trials. A 2022 randomised, double-blind, placebo-controlled trial in 100 adults showed that supplementation with a standardised Ocimum tenuiflorum extract for eight weeks significantly reduced post-stressor salivary cortisol, salivary amylase, and hair cortisol concentrations compared with placebo, demonstrating an effect on both the HPA axis and the sympathoadrenal medullary system.¹⁰

The bioactive profile centres on eugenol, ursolic acid, rosmarinic acid, and β-caryophyllene. Eugenol is responsible for much of the documented anti-stress activity, while ursolic acid contributes anti-inflammatory and immunomodulatory effects.¹⁰ Direct canine trials are limited, and Holy Basil is not currently a Bonza ingredient. It is a strong candidate for future spoke development and inclusion in canine stress and behaviour-focused supplements.

Secondary Adaptogens: Six More With Documented Adaptogenic Action

Six further botanicals meet the strict adaptogen criteria with established but less extensive evidence than the Core six. They are Astragalus, Cordyceps, Reishi, Maca, Liquorice, and Shatavari. Each has demonstrable HPA-axis or systemic stress-response activity, identifiable bioactives, and documented safety at therapeutic dose.²

The six Secondary adaptogens differ in the systems they emphasise:

• Astragalus (Astragalus membranaceus). Adaptogenic and immunomodulatory action driven by astragalosides and polysaccharides. Particularly relevant for immune resilience and recovery from chronic illness.
• Cordyceps (Cordyceps sinensis / militaris). Adaptogenic with strong evidence for energy metabolism and exercise tolerance, mediated by cordycepin and beta-glucan polysaccharides.
• Reishi (Ganoderma lucidum). Adaptogenic mushroom characterised by triterpenoids (ganoderic acids) and immunomodulatory beta-glucans. A 2024 canine intervention study documented functional benefits of supplementation in healthy dogs at controlled inclusion levels.¹¹ Reishi is included in PhytoPlus^® within Bonza Superfoods & Ancient Grains.
• Maca (Lepidium meyenii). Andean adaptogen with documented effects on energy, endurance, and reproductive endocrinology. Bioactives include macamides and macaenes.
• Liquorice root (Glycyrrhiza glabra). Adaptogenic via glycyrrhizin and modulation of glucocorticoid metabolism. Use is restricted in cardiovascular and renal compromise and requires veterinary input in dogs.
• Shatavari (Asparagus racemosus). Adaptogenic with traditional use centred on female reproductive health, mediated by steroidal saponins (shatavarins). Limited canine evidence base.

Together, the Core and Secondary lists comprise the twelve botanicals that the modern adaptogen literature treats as defensibly within the strict-taxonomy category.²

Commonly Mislabelled: Why Turmeric, Ginger, and Echinacea Are Not Adaptogens

Several widely used functional herbs are routinely sold as adaptogens despite failing the strict pharmacological definition. The most common are turmeric, ginger, echinacea, ginkgo biloba, and milk thistle. Each has genuine functional value, but each operates through a single primary mechanism rather than the bidirectional, non-specific HPA modulation that defines adaptogens.¹,²

This distinction is not pedantic. It changes what a herb can and cannot do for your dog.

• Turmeric (Curcuma longa). A potent anti-inflammatory and antioxidant via curcuminoids, with no documented HPA-axis modulation or normalising bidirectional behaviour. It is a category-leading anti-inflammatory and oxidative-stress agent. It is not an adaptogen.
• Ginger (Zingiber officinale). An anti-inflammatory, antiemetic, and circulation-supporting herb via gingerols and shogaols. It does not raise non-specific resistance to stress and lacks the normalising action defining the category.
• Echinacea (Echinacea purpurea / angustifolia). An immunomodulator, primarily acute-phase, with documented support for short-term immune challenge. It is not adaptogenic; its action is directional rather than bidirectional.
• Ginkgo biloba. A nootropic with effects on cerebral microcirculation and platelet aggregation via ginkgolides and bilobalide. Genuine cognitive and circulatory effects, but not HPA-axis adaptogenic activity.
• Milk Thistle (Silybum marianum). A hepatoprotective via silymarin, particularly silibinin, with strong support for hepatic membrane stabilisation and glutathione regeneration. Not an adaptogen; the action is organ-specific and protective rather than systemically normalising.

If a label describes any of these as adaptogens, it is using the term loosely. That does not mean the product is a poor product. It means the marketing language has decoupled from the pharmacology, which is worth noticing when you are selecting on the basis of category claims.

Adaptogens Are Not Calming Herbs: A Critical Distinction

Calming nervines and adaptogens are sometimes lumped together because both are used in stress-related contexts, but they are pharmacologically distinct categories with different mechanisms, different time courses, and different therapeutic places. Conflating them leads to dog owners using one when they need the other, and to disappointing outcomes from products chosen for the wrong category of effect.

The four most common calming nervines marketed alongside adaptogens are Chamomile (Matricaria recutita), Lavender (Lavandula angustifolia), Passionflower (Passiflora incarnata), and Lemon Balm (Melissa officinalis). All four are valuable, but none meets the adaptogen definition. Their mechanisms are GABAergic, anxiolytic, or sedative rather than HPA-axis normalising. They tend to act acutely (within hours) rather than progressively (over weeks). They reduce arousal in one direction rather than restoring equilibrium across both.

The two categories complement rather than substitute. A reactive dog may benefit from a strict-definition adaptogen as a long-term resilience layer and a calming nervine as an acute-context tool for thunderstorms, vet visits, or fireworks. Treating them as interchangeable, as much marketing copy implicitly does, is a mistake. The Calming and Mood Hub for Dogs covers the nervine category in detail and is the appropriate reference for calming-herb selection.

How Adaptogens Work in Dogs: HPA Axis, Cortisol Modulation, and Allostatic Load

Adaptogens act on the dog’s stress-response machinery by modulating the hypothalamic-pituitary-adrenal (HPA) axis and the cellular heat-shock and oxidative-stress response systems, with the result that resilience improves and the wear-and-tear of chronic stress, known as allostatic load, accumulates more slowly.¹,²,¹²

The dog’s HPA axis follows the same architecture as the human equivalent. Perceived stress activates corticotropin-releasing hormone (CRH) in the hypothalamus, which triggers adrenocorticotropic hormone (ACTH) from the pituitary, which in turn drives cortisol release from the adrenal cortex. In acute stress, cortisol mobilises energy, sharpens vigilance, and recruits the immune system. In chronic stress, sustained cortisol elevation produces the well-documented downstream effects familiar to anyone working with anxious or rescue dogs: gut dysbiosis, suppressed immune function, hippocampal volume changes, behavioural reactivity, and accelerated ageing.¹²

Allostatic load, the concept developed by Bruce McEwen and colleagues, describes the cumulative biological cost of repeated or sustained stress activation: the wear and tear that emerges when the systems built for short-term adaptation are pressed into long-term service.¹² In dogs, allostatic load shows up clinically as the chronically reactive dog who never quite resets, the senior dog whose immune resilience and gut function decline together, and the working dog whose performance plateaus despite training and conditioning.

Adaptogens operate as modulators of this system rather than blockers of any single component. The pharmacological data show that recognised adaptogens regulate cortisol bidirectionally, induce protective heat-shock proteins (Hsp70), modulate stress-activated kinases (JNK1), and influence transcription factors including FOXO/DAF-16 that are central to longevity signalling.¹,² The clinical observation in animal and human studies is that dogs and humans treated with adaptogens become better at handling stressors rather than less responsive to them. This is the practical meaning of normalising action.

Adaptogens and the Gut-Organ Axes

Adaptogens influence canine health through the gut-organ axes because the HPA axis and the gut microbiome are physically and chemically interlinked, and because several adaptogens additionally produce direct effects on intestinal physiology and microbial metabolism.⁵ The most relevant axes for adaptogen action are the Gut-Brain axis (primary), the Gut-Immune axis, and the Gut-Longevity axis.

The Gut-Brain axis is the dominant route. Stress activates the HPA axis, and HPA activation alters intestinal motility, secretion, mucus production, and microbial composition. Conversely, microbial metabolites including short-chain fatty acids (SCFAs) signal back to the central nervous system through vagal, immune, and endocrine pathways, modulating both basal and reactive HPA tone. The 2025 Bharani trial in geriatric Beagles is the most direct illustration in dogs: 60 days of Ashwagandha root extract at 15 mg/kg significantly increased faecal propionic acid and total SCFAs, increased plasma L-citrulline (a recognised marker of intestinal integrity), reduced ALT and AST while keeping all values in physiological range, and improved faecal score, all while modulating the gut microbial metabolite environment.⁵ This is HPA-axis modulation and gut-axis modulation expressing as one continuous physiological effect, exactly as the gut-brain literature would predict.

The Gut-Immune axis is the second route. Adaptogens with documented immunomodulatory action, including Eleuthero, Astragalus, Reishi, and Cordyceps, exert systemic immune effects partly through the gut-associated lymphoid tissue (GALT), which sits at the interface between microbial metabolites and the broader immune system.⁸,¹¹ The Gut-Longevity axis is the third route, and is particularly relevant for senior dogs: bidirectional cortisol regulation reduces allostatic load, improves antioxidant capacity, and supports the metabolic profile of healthy ageing, all of which converge on the gut-microbiome and longevity literature.

For deeper coverage of how the gut microbiome connects to systemic health, see The Dog Gut Microbiome – Vital Key To Dog Health and the relevant axis articles linked at the end of this guide.

Safety, Dosage, and When Adaptogens Should Not Be Used in Dogs

Adaptogens are characterised pharmacologically by a favourable safety profile at therapeutic dose, but favourable is not the same as universally safe, and species-appropriate dosing matters. In dogs, the strongest published dose evidence is for Ashwagandha root extract at 15 mg/kg body weight once daily, used in three RCTs over four to nine weeks without reported adverse events.³,⁴,⁵ Other adaptogens lack equivalent canine dose data and should be used at conservative doses with veterinary input.

A small number of contexts warrant caution or avoidance:

• Pregnancy and lactation. Insufficient canine safety data exists for any adaptogen during pregnancy or lactation; avoidance is the appropriate default.
• Concurrent immunosuppressive medication. Several adaptogens, including Astragalus, Eleuthero, and Reishi, have immunomodulatory activity that may interact with immunosuppressive protocols; veterinary review is essential.
• Cardiovascular medication and hypertension. Liquorice root requires particular caution given its mineralocorticoid-like effects on potassium and blood pressure. Panax ginseng can interact with antihypertensive and anticoagulant regimens; veterinary input is required.
• Sedatives and psychotropics. Veterinary review is sensible before combining adaptogens with prescribed behaviour-modifying medication, as bidirectional HPA action can interact with the underlying drug effect.
• Active autoimmune disease. Immunomodulatory adaptogens warrant veterinary supervision in autoimmune contexts.
• Puppies under 12 months and toy breeds at extreme low body weight. Dose calibration should be conservative and veterinary-led.

The general principle is that adaptogens are best introduced gradually, observed over weeks rather than days, and used as part of a broader strategy rather than as a standalone intervention. The most consistent positive results in the canine literature come from sustained daily dosing over four to nine weeks, not from intermittent high doses.³,⁴,⁵

Why the Bonza Range Is Built Around Strict-Definition Adaptogens

Bonza is the only UK plant-based dog brand whose food and supplement range is architected around strict-definition adaptogens applied by pharmacology to specific functional classes. The architecture has two layers: a food layer that delivers four strict-definition adaptogens daily through the proprietary PhytoPlus® botanical blend, and a supplement layer that applies specific adaptogens to specific Bioactive Bites where their pharmacology fits the functional class.

The food layer centres on Superfoods & Ancient Grains. PhytoPlus® contains four strict-definition adaptogens: Ashwagandha, Panax Ginseng, Eleuthero, and Reishi. Three of the four (Ashwagandha, Panax Ginseng, Eleuthero) are Core adaptogens, the category with the strongest pharmacological and clinical evidence base. The fourth (Reishi) is a Secondary adaptogen.

Each adaptogen in the food brings a different shape of support:

• Ashwagandha brings the strongest dog-specific evidence base for HPA-axis modulation, anti-inflammatory action, and gut-axis benefit, with three peer-reviewed canine RCTs to date.³,⁴,⁵
• Panax Ginseng is the original adaptogen reference plant of East Asian herbal medicine, with bidirectional cortisol modulation as the canonical example of normalising action across cardiovascular, neuroendocrine, and immune systems.⁷
• Eleuthero brings the foundational adaptogen on which the modern category was effectively built, with documented HPA-axis effects, neuroprotective activity via brain-derived neurotrophic factor, and anti-fatigue properties.¹,⁸
• Reishi provides a Secondary adaptogen with immunomodulatory triterpenoids and beta-glucans, complementing the broader fibre-and-microbiome architecture of the food and contributing to immune resilience.¹¹

The supplement layer applies specific adaptogens to specific functional classes within the Bioactive Bites range. Bliss, the calming and anxiety supplement, contains Ashwagandha for HPA-axis and cortisol modulation. Bounce, the joint and mobility supplement, contains Ashwagandha for anti-inflammatory and antioxidant support. Boost, the whole-body wellness and longevity supplement, contains both Ashwagandha and Eleuthero, layering HPA-axis and antioxidant support with anti-fatigue and neuroprotective action.

The range architecture means that adaptogenic support is not confined to a single product. PhytoPlus® as a blend remains exclusive to Superfoods & Ancient Grains, but the individual adaptogens that meet the strict pharmacological definition appear elsewhere in the range where their inclusion is pharmacologically warranted. The placement principle is consistent throughout: adaptogens are most effective when delivered daily over weeks, in a matrix that supports the gut microbiome through diverse fibre, polyphenol, and prebiotic content, and in a form that aligns the ingredient with the functional class of the product it sits within.

The one-line summary is straightforward: Bonza positions adaptogenic support not as a single-product claim but as a whole-range architecture, because that is how the underlying pharmacology actually works.

How to Choose Adaptogenic Support for Your Dog: A Practical Framework

Choosing adaptogenic support for your dog is a question of matching strict-definition pharmacology to the dog in front of you, not of selecting on the basis of category labels. A practical framework rests on five questions, applied in order.

Five questions to apply when comparing products or ingredients:

• Is the named ingredient a strict-definition adaptogen? Cross-check against the Core or Secondary lists in this guide. If the product names turmeric, ginger, echinacea, ginkgo, or milk thistle as the adaptogen, the labelling is loose.
• Is the dose specified, and is it within the canine evidence range? For Ashwagandha, the published canine dose is 15 mg/kg root extract daily.³,⁴,⁵ For other adaptogens, dose data is more limited and conservative dosing with veterinary input is appropriate.
• Is the form standardised to a recognised marker compound? For Ashwagandha, withanolide content. For Rhodiola, rosavin and salidroside. For Eleuthero, eleutheroside B and E. For Reishi, triterpenoid and beta-glucan content. Standardisation is what separates a reliable raw material from a botanical with high batch-to-batch variation.
• Does the dog’s situation match the adaptogen’s emphasis? Anti-anxiety, anti-fatigue, immune resilience, geriatric support, and post-illness recovery all benefit from adaptogens, but different adaptogens emphasise different parts of the stress-response architecture.
• Are there contraindications relevant to your dog? Concurrent medication, pregnancy, autoimmune disease, and very young or very small dogs all warrant veterinary review before introduction.

The single most useful behaviour change for dog owners reading the supplement aisle is to stop taking the word “adaptogen” on a label at face value. The category is real and useful; most products invoking the category are not within it. Once you can tell the difference, the choice becomes much simpler.

Frequently Asked Questions

Conclusion

The word adaptogen has been borrowed and bent so often that it is easy to miss the underlying pharmacology. Brought back to its strict definition, the category is small, well-defined, and genuinely useful for dogs facing stress, recovery, or healthy-ageing demands. Twelve botanicals qualify, six in the Core list and six in the Secondary list. Many more are sold under the label without belonging to it. Turmeric, ginger, and echinacea are not adaptogens. Chamomile, lavender, passionflower, and lemon balm are calming nervines, not adaptogens. The distinction is not pedantry; it determines what you should expect from the product on the shelf.

For dog owners, the practical implication is that strict-definition adaptogens have a defensible place in the long-term resilience layer of canine nutrition, particularly for stressed, reactive, recovering, or ageing dogs. The published canine evidence for Ashwagandha, supported by translational evidence for the wider category, makes the case as strongly as it has ever been made. The framework matters more than any single ingredient, and the framework rewards owners who learn to tell the difference between an adaptogen and a marketing label.

Related Articles

• The Dog Gut Microbiome – Vital Key To Dog Health
• The Gut-Brain Axis in Dogs: Nutritional Impact on Behaviour and Cognition
• The Gut-Immune Axis in Dogs
• The Gut-Longevity Axis in Dogs: Key To Improved Healthspan
• Bonza Superfoods & Ancient Grains

References

1. Panossian A, Wikman G. Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity. Pharmaceuticals (Basel). 2010;3(1):188-224. doi: 10.3390/ph3010188. PMID: 27713248. PMC: PMC3991026.
2. Panossian AG, Efferth T, Shikov AN, Pozharitskaya ON, Kuchta K, Mukherjee PK, Banerjee S, Heinrich M, Wu W, Guo D, Wagner H. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med Res Rev. 2021;41(1):630-703. doi: 10.1002/med.21743. PMID: 33103257. PMC: PMC7756641.
3. Kaur J, Seshadri S, Golla KH, Sampara P. Efficacy and safety of standardized Ashwagandha (Withania somnifera) root extract on reducing stress and anxiety in domestic dogs: A randomized controlled trial. J Vet Behav. 2022;51:8-15. doi: 10.1016/j.jveb.2022.03.002.
4. Bharani KK, Devarasetti AK, Carey L, Khurana A, Kollipaka R, Hanuman DDV, Chetla VS, Banothu AK. Effects of ashwagandha (Withania somnifera) root extract on aging-related changes in healthy geriatric dogs: A randomized, double-blinded placebo-controlled study. Vet Med Sci. 2024;10(4):e1556. doi: 10.1002/vms3.1556. PMID: 39078383. PMC: PMC11288135.
5. Bharani KK, Devarasetti AK, Bobbili R, Khurana A, Veera Hanuman DD, Gudepu R, Guda S. The role of Ashwagandha in modulating gut parameters in dogs – a randomized double-blind placebo-controlled trial. Front Vet Sci. 2025;11:1491989. doi: 10.3389/fvets.2024.1491989. PMID: 39911483. PMC: PMC11794502.
6. Ivanova Stojcheva E, Quintela JC. The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions – Encouraging Clinical Evidence. Molecules. 2022;27(12):3902. doi: 10.3390/molecules27123902. PMID: 35745023. PMC: PMC9228580.
7. Irfan M, Kwak YS, Han CK, Hyun SH, Rhee MH. Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions. J Ginseng Res. 2020;44(4):538-543. doi: 10.1016/j.jgr.2020.03.001. PMID: 32617033. PMC: PMC7322748.
8. Kos G, Czarnek K, Sadok I, Krzyszczak-Turczyn A, Kubica P, Fila K, Emre G, Tatarczak-Michalewska M, Latalska M, Blicharska E, Załuski D, Şekeroğlu N, Szopa A. Eleutherococcus senticosus (Acanthopanax senticosus): An Important Adaptogenic Plant. Molecules. 2025;30(12):2512. doi: 10.3390/molecules30122512. PMID: 40572479. PMC: PMC12195798.
9. Nowak A, Zakłos-Szyda M, Błasiak J, Nowak A, Zhang Z, Zhang B. Potential of Schisandra chinensis (Turcz.) Baill. in Human Health and Nutrition: A Review of Current Knowledge and Therapeutic Perspectives. Nutrients. 2019;11(2):333. doi: 10.3390/nu11020333. PMID: 30720717. PMC: PMC6412213.
10. Lopresti AL, Smith SJ, Metse AP, Drummond PD. A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer) on stress, mood, and sleep in adults experiencing stress. Front Nutr. 2022;9:965130. doi: 10.3389/fnut.2022.965130. PMID: 36185698. PMC: PMC9524226.
11. Tanprasertsuk J, Tate DE, Shmalberg J. Roles of plant-based ingredients and phytonutrients in canine nutrition and health. J Anim Physiol Anim Nutr (Berl). 2024;102:skae051. doi: 10.1093/jas/skae051. PMID: 38417056. PMC: PMC11025632.
12. McEwen BS. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci. 2000;896:30-47. doi: 10.1111/j.1749-6632.1999.tb08103.x. PMID: 10681886.

Editorial Information

Field	Detail
Published	April 2026
Last Updated	April 2026
Reviewed by	Glendon Lloyd Dip.Canine.Nutrition Dip.Dog.Nutrigenomics
Next Review	October 2026
Author	Glendon Lloyd Dip.Canine.Nutrition Dip.Dog.Nutrigenomics
Disclaimer	This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen.